Welcome to our dedicated page for Celanese Del SEC filings (Ticker: CE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Celanese Corporation (NYSE: CE) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures, including Form 8-K current reports and other documents filed with the U.S. Securities and Exchange Commission. Celanese is a global specialty materials and chemical company in the basic organic chemical manufacturing industry, and its filings offer detailed insight into its financing activities, governance developments and operational decisions.
Recent Form 8-K filings describe a range of material events. Several filings outline registered offerings of senior notes by Celanese US Holdings LLC, a wholly owned subsidiary, including 7.000% Senior Notes due 2031 and 7.375% Senior Notes due 2034. These filings explain that net proceeds are used to repay borrowings under a five-year term loan credit agreement due 2027, fund cash tender offers for outstanding senior notes due 2027 and 2028, and support general corporate purposes, which may include repayment of other indebtedness.
Other 8-K reports cover cash tender offers for the company’s 6.665% Senior Notes due 2027 and 6.850% Senior Notes due 2028, including announcements of the commencement of tender offers, early results and increases in the maximum tender amount and series cap. Additional filings detail a revolving credit agreement providing a five-year unsecured revolving credit facility and an amendment to an existing term loan credit agreement, including new covenant terms.
Celanese filings also document operational and portfolio actions, such as the intended closure of an acetate tow production facility in Lanaken, Belgium, with associated expected non-cash accelerated depreciation and other shutdown costs, and the signing of a purchase and sale agreement to divest the Micromax® portfolio of products. Governance-related filings include the resignation of a Board member and the company’s explanation that the departure was not due to any disagreement on operations, policies or practices.
On Stock Titan, these SEC filings are presented with real-time updates from EDGAR and AI-powered summaries that help explain the key points of each document. Users can quickly understand the implications of Celanese’s 8-K disclosures, senior note offerings, credit agreements, tender offers and other reported events without reading every technical detail.
Murray Mark Christopher reported acquisition or exercise transactions in this Form 4 filing.
Celanese Corp senior vice president Mark Christopher Murray received new equity awards. On February 27, 2026, he was granted 14,561 nonqualified stock options with time-based vesting and 10,431 shares of common stock in the form of restricted stock units under the company’s 2018 Global Incentive Plan. The options and RSUs vest in three annual tranches from February 15, 2027 through February 15, 2029, subject to continued employment.
McGilvray Aaron M reported acquisition or exercise transactions in this Form 4 filing.
Celanese Corp Chief Accounting Officer Aaron M. McGilvray received new equity awards. He was granted nonqualified stock options for 2,355 shares and time-based restricted stock units covering 1,687 shares of common stock at no cost.
The RSUs vest 33% on February 15, 2027 and 2028, and 34% on February 15, 2029, if employment continues. The options vest in three annual installments of 33%, 33%, and 34% beginning February 15, 2027. He also reports indirect holdings through a 401(k) plan.
Celanese Corp reported that its SVP & CFO, Chuck Kyrish, received an equity compensation grant. He acquired 15,678 time-based restricted stock units, each convertible into one share of common stock under the company’s Amended and Restated 2018 Global Incentive Plan.
Kyrish was also granted 21,884 time-based nonqualified stock options under the same plan. The RSUs vest in portions of 33%, 33%, and 34% on February 15 of 2027, 2028, and 2029, while the options vest in three annual installments of 33%, 33%, and 34% beginning February 15, 2027, all subject to continued employment.
Elliott Todd L reported acquisition or exercise transactions in this Form 4 filing.
Celanese Corp senior vice president Todd L. Elliott reported equity awards that increase his direct holdings. On February 27, 2026, he received 17,558 nonqualified stock options and 12,579 time-based restricted stock units (RSUs) at no cash cost.
The RSUs, each representing one future share of common stock, vest with 33% on February 15, 2027, 33% on February 15, 2028, and 34% on February 15, 2029, subject to continued employment. The stock options vest on the same 33%, 33%, 34% annual schedule beginning February 15, 2027.
Duffie Ashley B reported acquisition or exercise transactions in this Form 4 filing.
Celanese Corp senior vice president and general counsel Ashley B. Duffie reported equity awards that increase her stake in the company. She received a grant of 14,561 nonqualified stock options and 10,431 shares of common stock, both awarded at a stated price of $0.00 per share.
The options are time-based employee stock options granted under the company’s Amended and Restated 2018 Global Incentive Plan and vest in three installments of 33%, 33% and 34% beginning on February 15, 2027. The common stock award consists of time-based restricted stock units, each representing one share of common stock, vesting 33% on each of February 15, 2027 and February 15, 2028, and 34% on February 15, 2029, all subject to continued employment.
Celanese Corporation files its Form 10-K describing a diversified global chemicals and engineered materials business with 51 production sites, 20 affiliate facilities and 11,434 employees as of December 31, 2025. The company operates through two main segments: Engineered Materials and the Acetyl Chain.
Engineered Materials supplies high‑performance polymers for automotive, medical, electronics and industrial uses, while the Acetyl Chain provides key intermediates like acetic acid, VAM, emulsions and EVA used in coatings, adhesives, packaging and construction. Strategic affiliates generated $1.9 billion of sales in 2025, contributing $78 million of equity earnings and $95 million of dividends.
Management reports a strong safety record, with a 2025 Total Recordable Incident Rate of 0.10 and Lost Time Incident Rate of 0.03. The filing highlights climate and sustainability initiatives, including carbon capture methanol, renewable energy projects and low‑carbon product lines, alongside an announced Scope 1 and 2 emissions reduction target disclosed in the 2024‑2025 Sustainability Report.
Financially, Celanese recorded a noncash goodwill impairment of $1.1 billion and $346 million of trade name impairments in Engineered Materials, and expects about $140 million of charges through 2027 from closing its Lanaken, Belgium facility. As part of deleveraging, the quarterly dividend was reduced by roughly 95% beginning in early 2025.
Celanese Corp CEO & President Scott A. Richardson reported equity compensation activity in the form of performance-based restricted stock units. On February 15, 2026, he acquired 3,336 shares of common stock at $0.00 per share upon the vesting and settlement of PRSUs originally granted on February 8, 2023.
To cover related tax obligations, 989 shares of common stock were disposed of at $59.12 per share through a tax-withholding transaction rather than an open-market sale. Following these transactions, his direct holdings increased to 72,795.703 common shares, with an additional 596.1055 shares held indirectly through a 401(k) plan.
Celanese Corp senior vice president Mark Christopher Murray reported equity compensation activity involving company common stock. On February 15, 2026, he acquired 1,205 shares at no cost through the vesting and settlement of performance-based restricted stock units originally granted on February 8, 2023.
On the same date, 357 shares were disposed of at a price of $59.12 per share to cover taxes owed on the PRSU vesting. After these transactions, he directly held 17,848 common shares of Celanese.
Celanese Corp Chief Accounting Officer Aaron M. McGilvray reported routine equity award activity in company common stock. On February 15, 2026, he acquired 173 shares at $0.00 per share from the vesting and settlement of performance-based restricted stock units granted in 2023. On the same date, 188 shares at $59.12 per share were withheld to cover taxes on these PRSUs and previously reported time-based restricted stock units, reflecting a tax-withholding disposition rather than an open-market sale. After these transactions, he directly owned 10,304.378 common shares and indirectly held 824.5446 shares through a 401(k) plan.
Celanese Corp SVP & CFO Chuck Kyrish reported routine equity compensation activity involving performance-based restricted stock units (PRSUs). He acquired 401 shares of common stock upon PRSU vesting and settlement, then disposed of 179 shares that were withheld to cover taxes, leaving 11,136.476 shares held directly.